This topic contains a solution. Click here to go to the answer

Author Question: What is the effect of an increase in the cooling load on a TXV? a. The superheat decreases, ... (Read 42 times)

meagbuch

  • Hero Member
  • *****
  • Posts: 568
What is the effect of an increase in the cooling load on a TXV?
 
  a. The superheat decreases, causing the TXV to feed more refrigerant.
  b. The superheat decreases, causing the TXV to reduce the flow of refrigerant.
  c. The superheat rises, causing the TXV to feed more refrigerant.
  d. The superheat rises, causing the TXV to reduce the flow of refrigerant.

Question 2

How does an automatic expansion valve prevent liquid floodback in a system?
 
  a. It is not capable of preventing floodback.
  b. Keeping the evaporator pressure low prevents floodback.
  c. Keeping the evaporator temperature low prevents floodback.
  d. Keeping the evaporator pressure high prevents floodback.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

beccamahon

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

c

Answer to Question 2

a





 

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library